RPTX: reparerx.com Net earnings per share for the last 12 months

Symbol and logo of brand Repare Therapeutics Inc. (RPTX)

Net income per share for the last four quarters in GURU.Markets features a linear chart containing yield data for Repare Therapeutics (RPTX), which is based on partnerships with pharma giants. Effective capital and scientific portfolio management, combined with a strong team of researchers, confirm the model's resilience. Meanwhile, the -1.69 mark records this indicator, allowing for a real-time assessment of the business's actual return without reporting time lags.

RPTX (Repare Therapeutics) Net earnings per share (EPS TTM) history from 07/04/2022 to 02/07/2026

Analytical breakdowns for Repare Therapeutics

- share price and expert price forecast:
Stock Quotes Repare Therapeutics Inc.|RPTX - Fair Value Consensus
- market capitalization information:
Market Valuation Repare Therapeutics Inc.|RPTX - Aggregate Business Value
- balance sheet net asset value indicators:
Book Value per Share Repare Therapeutics|RPTX - Book Capitalization|Market Value to Book Value Ratio reparerx.com|RPTX - Aggregate Asset Value
- business debt structure and liquidity details:
Total Debt to Capital Repare Therapeutics|RPTX - Long-Term Indebtedness to Equity|Short-Term Debt to Capital Repare Therapeutics, Inc.|RPTX - Company Cumulative Debt|Debt to Book Value Repare Therapeutics Inc.|RPTX - Amount of Long-Term Liabilities|Company Short-Term Debts Repare Therapeutics|Quick Ratio reparerx.com
- net income and valuation multiples indicators:
RPTX - Company Profit|Future Profit Repare Therapeutics|RPTX - Company Value to Net Income|Projected Price to Earnings Repare Therapeutics Inc.|RPTX - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Repare Therapeutics Inc|RPTX - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Repare Therapeutics|RPTX - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months reparerx.com|RPTX - Earnings per share increase in current year|Earnings growth forecast for next year Repare Therapeutics
- sales and revenue data:
RPTX - Revenue and Sales Volume|Company Projected Revenue Repare Therapeutics|RPTX - Price-to-Sales Ratio|Forward Price-to-Revenue Multiple Repare Therapeutics Inc.
Basic company analysis:Repare Therapeutics - RPTX
Manufactured products of Repare Therapeutics, Inc.

Repare Therapeutics (RPTX) develops highly scalable cancer therapies where patents provide the potential for global dominance. The eps_ttm_co metric reflects net income allocated per share over a trailing twelve-month period, excluding the impact of total issuance volume. The current value of -1.69 allows for a real-time assessment of the actual efficiency of intellectual property capitalization. Monitoring this metric is critical for distinguishing true business resilience from temporary stability. Analyzing this chart of net income per share over 12 months helps investors identify capital dilution risks in a timely manner.

Who Repare Therapeutics competes with

GMAB: Net earnings per share for the last 12 months|Earnings per share for the trailing year EXEL (Exelixis Corp)|NUVL (Nuvalent) - Net earnings per share for the last 12 months|KYMR: Earnings per share for the last four quarters|IDYA (IDEAYA Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) enliventherapeutics.com|Earnings per share for the last twelve months ORIC Pharmaceuticals, Inc. (ORIC)|RLAY (Relay Therapeutics, Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) NRIX (Nurix Therapeutics Inc)|Net earnings per share for the trailing year Tyra Bio|Verastem Oncology - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Monte Rosa Therapeutics, Inc.|CGEM (Cullinan Therapeutics) - Net earnings per share for the last 12 months|IMRX: Earnings per share for the last four quarters|CCCC (c4therapeutics.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Black Diamond Therapeutics Inc. BDTX|Net earnings per share (EPS TTM) PMVP|Karyopharm - Earnings per share for the last 12 months|Propanc Biopharma Inc - Net earnings per share for the last 12 months|Earnings per share for the trailing year BGMS|AADI: Net earnings per share for the last 12 months|aileronrx.com - Earnings per share for the last four quarters|BPMC: Net earnings per share (EPS TTM)|GlycoMimetics Inc. - Earnings per share for the trailing year|SWTX (SpringWorks Therapeutics, Inc) - Net earnings per share (EPS TTM)